204 related articles for article (PubMed ID: 19444398)
21. Clinical features and treatment outcomes of vitiligo from the patients' perspective: results of a national survey in Germany.
Radtke MA; Schäfer I; Gajur AI; Augustin M
Dermatology; 2010; 220(3):194-200. PubMed ID: 20203472
[TBL] [Abstract][Full Text] [Related]
22. Determination of skin repigmentation progression.
Nugroho H; Fadzil MH; Yap VV; Norashikin S; Suraiya HH
Annu Int Conf IEEE Eng Med Biol Soc; 2007; 2007():3442-5. PubMed ID: 18002737
[TBL] [Abstract][Full Text] [Related]
23. Vitiligo: Pathogenesis, clinical variants and treatment approaches.
Iannella G; Greco A; Didona D; Didona B; Granata G; Manno A; Pasquariello B; Magliulo G
Autoimmun Rev; 2016 Apr; 15(4):335-43. PubMed ID: 26724277
[TBL] [Abstract][Full Text] [Related]
24. Vitiligoid variant of lichen sclerosus in young girls with darker skin types.
Dennin MH; Stein SL; Rosenblatt AE
Pediatr Dermatol; 2018 Mar; 35(2):198-201. PubMed ID: 29314207
[TBL] [Abstract][Full Text] [Related]
25. Repigmentation of extensive inflammatory vitiligo with raised borders using early and aggressive treatment.
Gunasekera N; Murphy GF; Sheth VM
Dermatology; 2015; 230(1):11-5. PubMed ID: 25413601
[TBL] [Abstract][Full Text] [Related]
26. Recent investigations on vitiligo vulgaris.
Nordlund JJ; Majumder PP
Dermatol Clin; 1997 Jan; 15(1):69-78. PubMed ID: 9001862
[TBL] [Abstract][Full Text] [Related]
27. Combined therapy for resistant vitiligo lesions: NB-UVB, microneedling, and topical latanoprost, showed no enhanced efficacy compared to topical latanoprost and NB-UVB.
Stanimirovic A; Kovacevic M; Korobko I; Šitum M; Lotti T
Dermatol Ther; 2016 Sep; 29(5):312-316. PubMed ID: 27356486
[TBL] [Abstract][Full Text] [Related]
28. Vitiligo patients seeking depigmentation therapy: a case report and guidelines for psychological screening.
Grau C; Silverberg NB
Cutis; 2013 May; 91(5):248-52. PubMed ID: 23772431
[TBL] [Abstract][Full Text] [Related]
29. Treatments of vitiligo: what's new at the horizon.
Lotti TM; Hercogová J; Schwartz RA; Tsampau D; Korobko I; Pietrzak A; Mitrevska NT; Valle Y; Buggiani G
Dermatol Ther; 2012; 25 Suppl 1():S32-40. PubMed ID: 23237036
[TBL] [Abstract][Full Text] [Related]
30. CLINICAL EPIDEMIOLOGICAL PROFILE OF VITILIGO.
Kiprono S; Chaula B
East Afr Med J; 2012 Aug; 89(8):278-81. PubMed ID: 26852459
[TBL] [Abstract][Full Text] [Related]
31. International Initiative for Outcomes (INFO) for vitiligo: workshops with patients with vitiligo on repigmentation.
Eleftheriadou V; Hamzavi I; Pandya AG; Grimes P; Harris JE; Huggins RH; Lim HW; Elbuluk N; Bhatia B; Tovar-Garza A; Nahhas AF; Braunberger T; Ezzedine K
Br J Dermatol; 2019 Mar; 180(3):574-579. PubMed ID: 30030843
[TBL] [Abstract][Full Text] [Related]
32. Phototherapy for vitiligo, what's new?
Paro Vidolin A; Aurizi C; Leone G
G Ital Dermatol Venereol; 2017 Oct; 152(5):474-488. PubMed ID: 28906087
[TBL] [Abstract][Full Text] [Related]
33. Management of a vitiligo patient: a case study.
Thompson FV
Dermatol Nurs; 1993 Apr; 5(2):139-44. PubMed ID: 8507537
[TBL] [Abstract][Full Text] [Related]
34. A single-arm open-label clinical trial of autologous epidermal cell transplantation for stable vitiligo: A 30-month follow-up.
Orouji Z; Bajouri A; Ghasemi M; Mohammadi P; Fallah N; Shahbazi A; Rezvani M; Vaezirad F; Khalajasadi Z; Alizadeh A; Taghiabadi E; Dashtbozorgi S; Aghdami R; Hosseini SE; Bahahrvand H; Shafieyan S; Aghdami N
J Dermatol Sci; 2018 Jan; 89(1):52-59. PubMed ID: 29103774
[TBL] [Abstract][Full Text] [Related]
35. Effects of autologous micrografts on stable bilateral vitiligo: A focus on hand lesions.
Menchini G; Astarita C
J Dermatol; 2020 Dec; 47(12):1417-1423. PubMed ID: 32954507
[TBL] [Abstract][Full Text] [Related]
36. Dead Sea climatotherapy for vitiligo: a retrospective study of 436 patients.
Czarnowicki T; Harari M; Ruzicka T; Ingber A
J Eur Acad Dermatol Venereol; 2011 Aug; 25(8):959-63. PubMed ID: 21129041
[TBL] [Abstract][Full Text] [Related]
37. Psychodermatology of vitiligo: Psychological impact and consequences.
Simons RE; Zevy DL; Jafferany M
Dermatol Ther; 2020 May; 33(3):e13418. PubMed ID: 32297399
[TBL] [Abstract][Full Text] [Related]
38. The enigma and challenges of vitiligo pathophysiology and treatment.
Abdel-Malek ZA; Jordan C; Ho T; Upadhyay PR; Fleischer A; Hamzavi I
Pigment Cell Melanoma Res; 2020 Nov; 33(6):778-787. PubMed ID: 32198977
[TBL] [Abstract][Full Text] [Related]
39. Early-onset childhood vitiligo is associated with a more extensive and progressive course.
Mu EW; Cohen BE; Orlow SJ
J Am Acad Dermatol; 2015 Sep; 73(3):467-70. PubMed ID: 26118892
[TBL] [Abstract][Full Text] [Related]
40. Comparison of efficacy of noncultured hair follicle cell suspension and noncultured epidermal cell suspension in repigmentation of leukotrichia and skin patch in vitiligo: a randomized trial.
Gunaabalaji DR; Pangti R; Challa A; Chauhan S; Sahni K; Arava SK; Sethuraman G; Vishnubhatla S; Sharma VK; Gupta S
Int J Dermatol; 2020 Nov; 59(11):1393-1400. PubMed ID: 32989783
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
